Latest News about COVID/19 Coronavirus
Recent news which mentions COVID/19 Coronavirus
NRx Pharma Files Counterclaim Against Relief Therapeutics Over COVID-19 Candidate Rights
January 13, 2022
From Benzinga
From Benzinga
AstraZeneca's COVID-19 Vaccine Booster Against Omicron, Delta - New Data Supports Use
January 13, 2022
From Benzinga
Adagio's COVID-19 Antibody Has Neutralizing Activity Comparable To Other Antibodies
January 13, 2022
From Benzinga
WHO's Technical Body Says Updated COVID-19 Vaccines Needed To Combat Omicron: Reuters
January 12, 2022
From Benzinga
From Benzinga
Ocugen-Bharat Biotech Partnered COVID-19 Booster Covaxin Neutralizes Omicron, Delta Variants
January 12, 2022
Tickers
OCGN
From Benzinga
Quest Diagnostics Stock Falls As FY22 EPS Outlook Lags Consensus
January 12, 2022
Tickers
DGX
From Benzinga
Moderna COVID-19 Shot Lowers Risk Of Infection, Hospitalization Compared To Pfizer's, VA Real-World Data Shows
January 11, 2022
From Benzinga
From Benzinga
EXCLUSIVE: New On NASDAQ Deck, Revelation Bio's COVID-19 Antiviral Shows Encouraging Preclinical Action
January 11, 2022
From Benzinga
FDA Issues Clinical Hold On Immunome's COVID-19 Antibody Program
January 11, 2022
Tickers
IMNM
From Benzinga
From Benzinga
Novartis To In-License COVID-19 Treatment From Molecular Partners, After Encouraging Mid-Stage Data
January 10, 2022
From Benzinga
CureVac Outlines Upcoming Catalysts For Vaccine Programs
January 10, 2022
From Benzinga
From Benzinga
Pfizer To Provide US Additional 10M Courses Of COVID-19 Oral Therapy
January 04, 2022
Tickers
PFE
From Benzinga
Tonix Pharma, Kansas University Join Forces To Work On Next-Gen mRNA-Based COVID-19 Vaccine
January 04, 2022
From Benzinga
From Benzinga
From Benzinga
FDA Approves Pfizer's COVID-19 Booster For Age 12 To 15
January 03, 2022
From Benzinga
Sinovac's COVID-19 Vaccine With Pfizer Booster Less Effective Against Omicron: Reuters
January 03, 2022
From Benzinga
From Benzinga
From Benzinga
FDA Approves Another COVID-19 Antiviral Pill, This Time From Merck
December 23, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free
Information
Copyright 2024. BUSINESS INSURANCE HOLDINGS
